For instance, programmed cell death protein 4 (PDCD4) is methylated at R110 by PRMT5 to inhibit its anti-tumor properties, and the co-expression of PDCD4 and PRMT5 generates a tumor-promoting phenotype in an orthotopic breast cancer model [172]. This evidence concerns the gene PRMT5 and neoplasm.